about
ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studiesMulticenter analysis of glucocerebrosidase mutations in Parkinson's disease.Genome-wide association study reveals genetic risk underlying Parkinson's diseaseLarge-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseThe transcription factor PITX3 is associated with sporadic Parkinson's diseaseNeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseasesDeletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene.Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway.SNCA variants are associated with increased risk for multiple system atrophy.A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.Inflammatory profile in LRRK2-associated prodromal and clinical PDA genome-wide association study in multiple system atrophy.Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Prospective longitudinal course of cognition in older subjects with mild parkinsonian signsApolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants.Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans.Dual-Task Performance in GBA Parkinson's Disease.Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.Effect of genetic variation in Kv1.3 on olfactory function.Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.No association of GBA mutations and multiple system atrophy.A large genome scan for rare CNVs in amyotrophic lateral sclerosis.CHCHD2 and Parkinson's disease.GBA-associated PD presents with nonmotor characteristics.Comprehensive association analysis of the NOS2A gene with Parkinson disease.Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations.
P50
Q24305448-93FD26D0-65ED-4885-AB4E-5C0079C74E6DQ24606055-52D50ECE-120C-4213-9993-38E949B37C3FQ24634577-CEAC8562-0E0B-472A-AF4A-E81E2680F755Q24646654-740BA39F-E294-4308-9933-F3B75C1C16E7Q28244731-AE9C2D83-873A-4B45-8730-5BB14755F353Q28251266-C69E98F1-221A-498A-866F-BDD5988544F0Q28650457-BB2FE07E-B73D-4CCD-AA7A-80CF0D395029Q31063778-531BA07D-489B-4FFB-986A-D3ED313E9984Q33413497-C7B0E9B0-958F-4A51-8EEF-781362A5F37FQ33666819-ADF27D9D-8D00-481A-A0C1-DAAACDDE00EFQ34199600-58AE4B73-1B26-4180-9A0D-CC06D3E46A31Q34469280-4891C736-60E6-4C3D-A853-A69AFEE2CB8DQ35819806-F92BDC34-BB87-4BBC-B4A5-91DEFE518DD5Q36251993-D5034A56-F7D5-47DE-9229-D07F1972F802Q36411027-7CC2A829-8FE8-48BA-B486-0ADC9323B2FDQ36460907-60A5768B-E560-4E4C-B32D-16F50BA89E69Q36580714-4FFE2A7D-1EF6-42FD-812E-4BA1F7784EEFQ36934387-24A679A2-7FDD-4582-99EC-E2B5854E963FQ37345458-8E34A5A2-DCD5-4B05-B6F0-3B7211B75190Q37970653-5718B9F1-5164-40E5-9FE8-1CB7E46989C5Q38115298-6E0EEB0F-242D-4300-AB2E-8E97E96FC29AQ39304905-4E9DC962-EF58-4D91-A87D-C999C9C2C1EBQ39671039-6BDC01D8-8BDB-4E3B-B1FC-84A5697B15EEQ39849295-24227EAE-0892-43F3-810A-088D729EBEE6Q39860989-236C9624-D0AF-43AC-8218-C040F23E284DQ40369455-5DB93AA1-632F-447C-B549-9DA517A81B0FQ40460951-80005D12-FE60-4E4E-B3A2-7EF3088E3493Q41341655-A8CA2BCA-7871-4C03-B453-AFAF1AEBB163Q42495787-5512B113-92A2-4F61-B244-AE23ADC8A8E5Q45986506-80FBA35D-A231-4144-8214-0DD176841EA0Q46151649-0B085D52-7ED7-4E5F-B000-DAA2F0C4C9DAQ46174826-4158CAC6-547C-4C4E-BDB0-56FE1340110FQ46928589-92247625-16BA-4283-B0C6-994B164F9918Q48100339-AF04D892-F611-4152-97FA-A7F0BF20F609Q48132939-E23CC259-472B-42E6-A2B3-CB4DB898AD9FQ48294251-2BEC36AC-CD14-4754-83C1-F778F04A8302Q48341996-50F01204-296C-4C70-9965-BD20F13130B2Q48350333-47C29CBF-E82D-4AC6-8F97-13A02C73E124Q48436320-791C2B0C-B182-465F-9E9D-51E2C8B76CA3Q48459541-BA403B50-9798-49AD-A441-E766A608494B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudia Schulte
@ast
Claudia Schulte
@en
Claudia Schulte
@es
Claudia Schulte
@nl
Claudia Schulte
@sl
type
label
Claudia Schulte
@ast
Claudia Schulte
@en
Claudia Schulte
@es
Claudia Schulte
@nl
Claudia Schulte
@sl
altLabel
C Schulte
@en
Schulte C
@en
prefLabel
Claudia Schulte
@ast
Claudia Schulte
@en
Claudia Schulte
@es
Claudia Schulte
@nl
Claudia Schulte
@sl
P106
P1153
36887226900
P21
P31
P4012
P496
0000-0003-4006-1265